In His First Media Interview Ranbaxy CEO Arun Sawhney Discusses U.S. FDA Saga And Atorvastatin Launch
This article was originally published in PharmAsia News
Executive Summary
Uncharacteristically, the reticent and seasoned CEO opened up on a host of untold stories at Ranbaxy